Syra Health Corp.
SYRA
$0.1043
-$0.0228-17.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 44.73% | 35.47% | 25.18% | 3.72% | -1.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.73% | 35.47% | 25.18% | 3.72% | -1.83% |
| Cost of Revenue | 54.12% | 29.50% | 15.42% | -5.89% | -10.47% |
| Gross Profit | 17.36% | 60.19% | 72.57% | 54.37% | 36.61% |
| SG&A Expenses | 19.03% | 43.86% | 45.03% | 36.30% | 29.02% |
| Depreciation & Amortization | 28.22% | 45.49% | 43.57% | 87.88% | 228.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.80% | 45.93% | 37.77% | 17.45% | 9.02% |
| Operating Income | -30.38% | -69.83% | -66.15% | -51.76% | -38.19% |
| Income Before Tax | -27.94% | -66.30% | -63.83% | -51.22% | -38.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.94% | -66.30% | -63.83% | -51.22% | -38.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.94% | -66.30% | -63.83% | -51.22% | -38.73% |
| EBIT | -30.38% | -69.83% | -66.15% | -51.76% | -38.19% |
| EBITDA | -30.41% | -69.84% | -66.06% | -50.94% | -36.41% |
| EPS Basic | 9.83% | -14.73% | -17.91% | -0.94% | 44.60% |
| Normalized Basic EPS | 9.87% | -14.70% | -17.85% | -0.93% | 44.60% |
| EPS Diluted | 9.83% | -14.73% | -17.91% | -0.94% | 44.60% |
| Normalized Diluted EPS | 9.87% | -14.70% | -17.85% | -0.93% | 44.60% |
| Average Basic Shares Outstanding | 55.17% | 46.53% | 32.45% | 34.18% | 54.70% |
| Average Diluted Shares Outstanding | 55.17% | 46.53% | 32.45% | 34.18% | 54.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |